Schmalbrock, Lilly J;Kager, Nils;Kirchhoff, Florian;Schiele, Stefan;Dinkel, Andreas;Gschwend, Jürgen E;Herkommer, Kathleen
Self-efficacy in long-term prostate cancer survivors.
Int. J. Clin. Health Psychol.
2025
25
4

Meissner, Valentin H;Söhne, Victoria A;Dinkel, Andreas;Jahnen, Matthias;Schiele, Stefan;Kron, Martina;Gschwend, Jürgen E;Herkommer, Kathleen
Dimensions of sexual self-concept and sexual dysfunctions in middle-aged men: results of the Bavarian Men's Health-Study.
Int J Impot Res
2025

Falkenbach, Fabian;Lischewski, Flemming;Knipper, Sophie;Koehler, Daniel;Karakiewicz, Pierre I;Tian, Zhe;Saad, Fred;Tilki, Derya;Budäus, Lars;Steuber, Thomas;Mandel, Philipp;Wenzel, Mike;Gschwend, Jürgen E;Graefen, Markus;Heck, Matthias M;Maurer, Tobias
Prostate-specific Membrane Antigen-radioguided Surgery in an EMBARK-like Cohort of Patients with Oligorecurrent Hormone-sensitive Prostate Cancer: Delay in Systemic Treatment.
Eur Urol Focus
2025
11
3
515-518

Jahnen, Matthias;Bierwirth, Charlotte;Meissner, Valentin H;Dinkel, Andreas;Schiele, Stefan;Schulwitz, Helga;Gschwend, Jürgen E;Herkommer, Kathleen
Cancer-related identity and advanced old age - analysis of prostate cancer survivors after radical prostatectomy over the age of 75.
BMC Geriatr
2025
25
1

Morgans, Alicia K;Chehrazi-Raffle, Alex;Niazi, Tamim;Shore, Neal D;Ross, Ashley E;Røder, Andreas;Gomes, Andrea Juliana;Supiot, Stephane;Barthélémy, Philippe;Hatano, Koji;Ruiz, Carmen Belen Congregado;Yoshida, Soichiro;Herrera-Imbroda, Bernardo;Gratton, Matthieu;Gschwend, Jürgen E;Hope, Thomas A;Joensuu, Heikki;Kuss, Iris;Le Berre, Marie-Aude;Dimova-Dobreva, Miryana;Fizazi, Karim
Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP).
Future Oncol
2025
21
27
3491-3498

Powles, Thomas;Kann, Ariel G;Castellano, Daniel;Gross-Goupil, Marine;Nishiyama, Hiroyuki;Bracarda, Sergio;Bjerggaard Jensen, Jørgen;Makaroff, Lydia;Jiang, Shusuan;Ku, Ja Hyeon;Park, Se Hoon;Reig Torras, Oscar;Ye, Dingwei;Maruzzo, Marco;Necchi, Andrea;Morales-Barrera, Rafael;Giunta, Emilio Francesco;Lee, Jae Lyun;Tortora, Giampaolo;Ürün, Yüksel;Dolowy, Lukasz;Erdem, Dilek;Pinto, Alvaro;Grando, Fabricio;Zou, Wei;Assaf, Zoe June;Vuky, Jacqueline;Degaonkar, Viraj;Steinberg, Elizabeth E;Bellmunt, Joaquim;Gschwend, Jürgen E
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer.
N Engl J Med
2025
393
24
2395-2408

Bergmann, L;Albiges, L;Ahrens, M;Gross-Goupil, M;Boleti, E;Gravis, G;Fléchon, A;Grimm, M-O;Bedke, J;Barthélémy, P;Castellano, D;Mellado, B;Ivanyi, P;Rottey, S;Flörcken, A;Suarez, C;Maroto, P;Grünwald, V;Oosting, S F;Kopecky, J;Zschäbitz, S;Boegemann, M;Buchler, T;Niegisch, G;Goebell, P J;Waddell, T;Joly, F;Priou, F;Retz, M;Siemer, S;Zimmermann, U;Deckbar, D;Burkholder, I;Hartmann, A;Haanen, J B
Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial.
Ann Oncol
2025
36
7
796-806

Meissner, Valentin H;Dinkel, Andreas;Kron, Martina;Schiele, Stefan;Jahnen, Matthias;Lakes, Jale;Radtke, Jan Philipp;Kuczyk, Markus A;Harke, Nina N;Debus, Jürgen;Fink, Christoph A;Antoch, Gerald;Schimmöller, Lars;Kristiansen, Glen;Krilaviciute, Agne;Seibold, Petra;Behrens, Sabine;Benner, Axel;Arsov, Christian;Hadaschik, Boris;Becker, Nikolaus;Kaaks, Rudolf;Albers, Peter;Gschwend, Jürgen E;Herkommer, Kathleen
Worry about prostate cancer and risk perception among middle-aged men: results from the PROBASE trial.
J Behav Med
2025
48
3
464-477

Al-Monajjed, Rouvier;Schimmöller, Lars;Radtke, Jan Philipp;Lakes, Jale;Krilaviciute, Agne;Schlemmer, Heinz-Peter;Herkommer, Kathleen;Seibold, Petra;Becker, Nikolaus;Kaaks, Rudolf;Hadaschik, Boris;Antoch, Gerald;Albers, Peter;Boschheidgen, Matthias
Characterisation of Multiparametric Magnetic Resonance Imaging of the Prostate in Younger Men with Normal Prostate-specific Antigen Within the PROBASE Study.
Eur. Urol. Open Sci.
2025
75
94-100

Graff, J N;Burotto, M;Fong, P C;Pook, D W;Zurawski, B;Manneh Kopp, R;Salinas, J;Bylow, K A;Kramer, G;Ratta, R;Kwiatkowski, M;Retz, M;Kwak, C;Arranz Arija, J A;Gurney, H;Matsubara, N;Villanueva, L;Todenhöfer, T;Liang, L W;Todoric, J;Imai, K;Stenzl, A
Pembrolizumab plus enzalutamide versus placebo plus enzalutamide for chemotherapy-naive metastatic castration-resistant prostate cancer: the randomized, double-blind, phase III KEYNOTE-641 study.
Ann Oncol
2025
36
8
976-987